RBL Bank Regulatory Approval

Annual General Meeting

RBL Bank Annual General Meeting

RBL Bank seeks shareholder approval via postal ballot for remuneration of its MD & CEO, an Executive Director and a retired ED. Voting runs October 28 to November 26, 2026.

Employee Stock Options

RBL Bank Employee Stock Options

RBL Bank allotted 5,28,745 ESOP shares to employees following exercise of vested options on October 26, 2026. Paid-up capital rose to 155.28 crore shares.

Earnings Call

RBL Bank Earnings Call Transcript: Key Takeaways

Strong balance sheet expansion driven by one-time FCNR(B) deposits and equity capital.

Management Change

RBL Bank Management Change

RBL Bank announced the appointment of Mr. Ashwini Kumar Choudhary as Chief Risk Officer and the re-appointment of Mr. Prakash Gupta as Chief Compliance Officer.

Earnings Call

RBL Bank Investor Presentation: Key Takeaways

RBL Bank reports strong Q2 FY27 performance with Net Profit surging 170% YoY to ₹4.82 bn. Growth driven by 37% NII expansion and significant improvement in asset quality.

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RBL Bank Q2 FY27 Results: Net Profit ₹498.4 Cr, Up 158.9% YoY

RBL Bank Ltd reported revenue from operations of ₹4,322 Cr (+23.2% YoY) and net profit of ₹498.4 Cr (+158.9% YoY) for Q2 FY27.

Key figure

Net profit ₹498.4 Cr · +158.9% YoY

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.